CABRI Announces Fellowship Opportunities for Undergraduate Research Traineeships

The Cayman Biomedical Research Institute (CABRI) is pleased to announce that applications for our undergraduate fellowships are open.

ANN ARBOR, Mich., Sept. 16, 2024 /PRNewswire-PRWeb/ -- Undergraduate fellowships are available on a competitive basis to undergraduate students who have been offered an unpaid research position by a qualified principal investigator. Up to $5,000 per academic year is available to each mentee-mentor team, with the entire amount paid as compensation to the undergraduate. The principal investigator will be responsible for the mentorship and guidance of the student during the period of the award.

"These fellowships are an excellent training opportunity for undergraduates to expand their knowledge outside the lecture hall," said Kourtney Goode, Academic Relations Coordinator at Cayman Chemical. "Hands-on research is an equally valuable learning experience that introduces a student to a potential career path and fosters the growth of their talents."

Undergraduate fellowship applications may be submitted on the CABRI website from September 10th to October 4th, 2024, and awardees will be notified by October 18th, 2024.

Contact CABRI with any questions about this funding opportunity.

About CABRI
Cayman Biomedical Research Institute (CABRI) is a nonprofit organization which supports research on the rare illnesses and orphan diseases that are often neglected by the corporate pharmaceutical industry and actively pursues new developments that will treat these diseases. To support this endeavor, we offer research grants to specific principal investigators at academic research institutions who have a plan to extend the clinical or preclinical development for these diseases as well as undergraduate grants to assist students to obtain experience in laboratories while performing research that aligns with CABRI's mission. CABRI also provides scholarships to college-bound students who have lost a parent to SNUC (sinonasal undifferentiated carcinoma) or B cell lymphoma.

Media Contact

Karin Dunbar, Cayman Biomedical Research Institute, 7349753945, [email protected], www.cabrimed.org

SOURCE Cayman Biomedical Research Institute